Topic:
M&A
Latest Headlines
Latest Headlines
Qiagen snatches up maker of amniotic fluid detection test
Qiagen ($QGEN) snatched up AmniSure International this week as the company continued to beef up its diagnostic offerings through acquisitions. AmniSure, a privately held company based in Boston, is known for marketing a point-of-care diagnostic that determines if a pregnant woman is suffering from a rupture of fetal membranes.
GSK's Witty has no interest in buying AstraZeneca
Thanks but no thanks. That was GlaxoSmithKline CEO Andrew Witty's comeback to the suggestion that maybe GSK should buy AstraZeneca.
GSK chief rules out AstraZeneca buyout
A buyout, he said, would be "very distracting".
Pharma's biotech buyouts stymied by price
Biotech shareholders don't want to sell at bargain prices. Pharma doesn't want to pay big premiums. Who's going to prevail?
Analysts size up Warner Chilcott's merits for sale
Bloomberg dug into the numbers to find Warner Chilcott delivers some sweet free cash flow, about 10 times more than the median among other specialty drugmakers.
Abbott hits the sweet spot, pays $110M cash for PhIIb drug
The cash deal delivers AP214, in development to prevent acute kidney injury associated with major cardiac surgery.
Synexus grabs Osteomed as its interest in Poland grows
Synexus, a European recruitment and trial management firm, announced its acquisition of Polish CRO Osteomed.
Novartis now top dog in skin drugs with $1.5B Fougera buy
Novartis has snapped up Fougera Pharmaceuticals, a U.S.-based maker of generic skin treatments, for $1.5 billion.
Pressure on premiums in M&A push biotech prices higher
Every week, it seems, a new biotech deal hits the radar screens. What's stopping the buyouts? Reuters' Ben Hirschler concludes that a handful of big shareholders at each of the target companies simply aren't interested in catering to Big Pharma's appetite for a bargain.
J&J buys first Chinese medical device company
Johnson & Johnson ($JNJ) made a big move in China this week with the purchase of its first medical device company in that country. It picked up Guangzhou Bioseal Biotech for an undisclosed sum.
